1. Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation
   Peng Gu et al, 2021, Oncology Reports CrossRef
2. Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer
   Gerd Wallukat et al, 2020, Autoimmunity Highlights CrossRef
3. A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment
   Mihnea P. Dragomir et al, 2020, Journal of Clinical Medicine CrossRef
4. Localized osteolysis
   Julie A. Rhoades (Sterling) et al, 2020, Principles of Bone Biology CrossRef
5. The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells
   Anna Maria Lucianò et al, 2020, International Journal of Molecular Sciences CrossRef